Zobrazeno 1 - 10
of 98
pro vyhledávání: '"K H, Bohuslavizki"'
Autor:
A. Hinsch, A. Luebke, W. Saeger, J. Lüttges, T. Clauditz, B. Rashed, K. H. Bohuslavizki, R. Issa, P. Dalquen
Publikováno v:
Der Pathologe. 37:465-472
Die diagnostischen Schwierigkeiten der Schilddrusenzytologie werden in der Literatur haufig diskutiert, aber nur selten wird den Ursachen und der Relevanz von sich widersprechenden zytologischen und histologischen Befunden im Einzelnen nachgegangen.
Autor:
Harshad R. Kulkarni, C Schuchardt, B. Volkmer, Richard P. Baum, K. H. Bohuslavizki, I. Klette, HJ Wester, A Singh
Publikováno v:
Der Nuklearmediziner. 38:145-152
Die Therapie des differenzierten Schilddrusenkarzinoms mit I-131 kann als paradigmatisch fur die Applikation einer theranostischen Substanz (Diagnostik und Therapie unter Anwendung des gleichen Vehikels) angesehen werden. Die erfolgreiche Behandlung
Autor:
P, Dalquen, B, Rashed, A, Hinsch, R, Issa, T, Clauditz, A, Luebke, J, Lüttges, W, Saeger, K H, Bohuslavizki
Publikováno v:
Der Pathologe. 37(5)
Diagnostic problems of thyroid cytology are frequently discussed, but relevance and causes of discrepant cytological and histological diagnoses are rarely studied in detail.Investigation of causes and relevance of discrepant diagnoses.The analysis in
Autor:
C. Bleckmann, K. H. Bohuslavizki
Publikováno v:
Der Nuklearmediziner. 26:8-12
Autor:
S Bachmann, Fritz Jänicke, J. Dose, C. R. Habermann, K. H. Bohuslavizki, Lars Jenicke, C Bleckmann, J Berger
Publikováno v:
Nuclear Medicine Communications. 23:857-864
The presence of distant metastases is the main prognostic factor in patients with breast cancer and has a significant influence in the choice of therapy. Therefore, chest X-ray, bone scintigraphy and ultrasound of the abdomen are performed to detect
Autor:
Ralph Buchert, H Schäfer, Lars Jenicke, D C Broering, K. H. Bohuslavizki, Malte Clausen, X Rogiers, Annette Fritscher-Ravens
Publikováno v:
Nuclear Medicine Communications. 22:1277-1285
Resectional surgery offers a curative intent and a survival benefit for patients with hilar cholangiocarcinoma, but is associated with high morbidity. Since morphological imaging cannot solve differential diagnosis preoperatively, in order to exclude
Publikováno v:
Nuklearmedizin. 40:228-238
SummaryIn 1995, the management of the University Clinic Hamburg-Eppendorf proposed to establish a total quality assurance (QA) system. A revised QA-system has been introduced stepwise in the department of nuclear medicine since 1997, and certificatio
Publikováno v:
Nuclear Medicine Communications. 22:779-783
Fever of unknown origin (FUO) is a diagnostic challenge, because the cause of such fever may be manifold. Studies on the use of positron emission tomography (PET) using 18F-fluorodeoxyglucose (18F-FDG), for the diagnosis of inflammation in patients w
Autor:
Lars Jenicke, K. H. Bohuslavizki, M. Geiss-Tönshoff, Malte Clausen, Janos Mester, S. Klutmann
Publikováno v:
Nuklearmedizin. 40:143-147
Summary Aim: The prevalence of iodine- and thyroglobulin-nega-tive findings was evaluated in all patients with differentiated thyroid cancer (DTC) treated from 1961 until 1998 at the Department of Nuclear Medicine, University Hospital Hamburg-Eppendo
Autor:
A. Sprenger, S. Klutmann, H. Ostertag, J. Lüttges, Willm Uwe Kampen, Eberhard Henze, K. H. Bohuslavizki, Norbert Czech, Winfried Brenner, U. zum Felde
Publikováno v:
Nuklearmedizin. 39:82-87
Summary Aim of this study was to prove the clinical value of nuclear medicine procedures to detect the sentinel lymph node (SLN) for SLN biopsy. Methods: In 132 patients with breast cancer we performed lymph scintigraphy of the breast as well as both